Tova Ronis

Dr. Tova Ronis

orcid

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
24 February 2020 in Journal of Clinical Investigation
Verified
Journal Article
Open access
PDF file
AJAdriana A. de Jesus
Adriana A. de Jesus
YHYangfeng Hou
Yangfeng Hou
SBStephen Brooks
Stephen Brooks
LMLouise Malle
Louise Malle
ABAngelique Biancotto
Angelique Biancotto
RGRaphaela Goldbach-Mansky
Raphaela Goldbach-Mansky
BACKGROUND. Undifferentiated systemic autoinflammatory diseases (USAIDs) present diagnostic and therapeutic challenges. Chronic interferon (IFN) signaling and cytokine dysregulation may identify diseases with available targeted treatments. METHODS. Sixty-six consecutively referred USAID patients underwent underwent screening for the presence of an interferon signature using a standardized type-I IFN-response-gene score (IRG-S), cytokine profiling, and genetic evaluation by next-generation sequencing. RESULTS. Thirty-six USAID patients (55%) had elevated IRG-S. Neutrophilic panniculitis (40% vs. 0%), basal ganglia calcifications (46% vs. 0%), interstitial lung disease (47% vs. 5%), and myositis (60% vs. 10%) were more prevalent in patients with elevated IRG-S. Moderate IRG-S elevation and highly elevated serum IL-18 distinguished 8 patients with pulmonary alveolar proteinosis (PAP) and recurrent macrophage activation syndrome (MAS). Among patients with panniculitis and progressive cytopenias, 2 patients were compound heterozygous for potentially novel LRBA mutations, 4 patients harbored potentially novel splice variants in IKBKG (which encodes NF-κB essential modulator [NEMO]), and 6 patients had de novo frameshift mutations in SAMD9L. Of additional 12 patients with elevated IRG-S and CANDLE-, SAVI- or Aicardi-Goutières syndrome–like (AGS-like) phenotypes, 5 patients carried mutations in either SAMHD1, TREX1, PSMB8, or PSMG2. Two patients had anti-MDA5 autoantibody–positive juvenile dermatomyositis, and 7 could not be classified. Patients with LRBA, IKBKG, and SAMD9L mutations showed a pattern of IRG elevation that suggests prominent NF-κB activation different from the canonical interferonopathies CANDLE, SAVI, and AGS. CONCLUSIONS. In patients with elevated IRG-S, we identified characteristic clinical features and 3 additional autoinflammatory diseases: IL-18–mediated PAP and recurrent MAS (IL-18PAP-MAS), NEMO deleted exon 5–autoinflammatory syndrome (NEMO-NDAS), and SAMD9L-associated autoinflammatory disease (SAMD9L-SAAD). The IRG-S expands the diagnostic armamentarium in evaluating USAIDs and points to different pathways regulating IRG expression. TRIAL REGISTRATION. ClinicalTrials.gov NCT02974595. FUNDING. The Intramural Research Program of the NIH, NIAID, NIAMS, and the Clinical Center.

28 March 2019 in Arthritis Care & Research
Verified
Journal Article
Closed access
PDF file
SASheila T. Angeles‐Han
Sheila T. Angeles‐Han
MLMindy S. Lo
Mindy S. Lo
LHLauren A. Henderson
Lauren A. Henderson
MLMelissa A. Lerman
Melissa A. Lerman
LALeslie Abramson
Leslie Abramson
TAthe Juvenile Idiopathic Arthritis Disease‐Specific and Uveitis Subcommittee of the Childhood Arthritis Rheumatology and Research Alliance
the Juvenile Idiopathic Arthritis Disease‐Specific and Uveitis Subcommittee of the Childhood Arthritis Rheumatology and Research Alliance

1 September 2004 in Journal of Allergy and Clinical Immunology
Verified
Journal Article
Closed access
OHOumnia Hajoui
Oumnia Hajoui
RJRamesh Janani
Ramesh Janani
Meri K. TulicMeri K. Tulic
Meri K. Tulic
Philippe JoubertPhilippe Joubert
Philippe Joubert
TRTova Ronis
Tova Ronis
BMBruce D. Mazer
Bruce D. Mazer

20 June 2018 in Nature Reviews Neurology
Verified
Journal Article
Closed access
PDF file
EWElizabeth Wells
Elizabeth Wells
YHYael Hacohen
Yael Hacohen
AWAmy Waldman
Amy Waldman
JTJan M. Tillema
Jan M. Tillema
ASAriane Soldatos
Ariane Soldatos
DWDavid Wessel
David Wessel

1 March 2014 in The Journal of Rheumatology
Verified
Journal Article
Closed access
PDF file
PCPeter Chira
Peter Chira
TRTova Ronis
Tova Ronis
SAStacy Ardoin
Stacy Ardoin
PWPatience White
Patience White
Objective.: To assess North American pediatric rheumatology providers’ perspectives on practices, barriers, and opportunities concerning the transition from pediatric-centered to adult-centered care.Methods.: Childhood Arthritis and Rheumatology Research Alliance (CARRA) members completed a 25-item survey assessing current transition practices, transition policy awareness, and transitional care barriers and needs. Results were compared to the American Academy of Pediatrics (AAP) 2008 survey on transitional care.Results.: Over half (158/288, 55%) of CARRA members completed the survey. Fewer than 10% are very familiar with AAP guidelines about transition care for youth with special healthcare needs. Eight percent have a formal written transition policy, but 42% use an informal approach. Patient request (75%) most frequently initiates transfer to adult care. Two major barriers to transition are fragmented adult medical care and lack of sufficient time to provide services. Compared with AAP survey participants, pediatric rheumatology providers are significantly more likely to help youth find an adult specialist (63% vs 45%) and discuss confidentiality and consent before age 18 (45% vs 33%), but are less likely to help with medical summary creation (16% vs 27%) or find a primary care provider (25% vs 47%). Outcomes ranked as “very important” in defining a successful transition are survival (76%), seeing an adult rheumatologist within 6 months of final pediatric rheumatology visit (66%), and maintaining insurance coverage (57%).Conclusion.: This comprehensive survey of North American pediatric rheumatology providers regarding transitional care practices demonstrates deficiencies in education, resources, and a formalized process. Respondents support development of standardized rheumatology-specific transition practices.

1 October 2021 in The Journal of Pediatrics
Verified
Journal Article
Closed access
RDRoberta L. DeBiasi
Roberta L. DeBiasi
AHAshraf S. Harahsheh
Ashraf S. Harahsheh
HSHemalatha Srinivasalu
Hemalatha Srinivasalu
AKAnita Krishnan
Anita Krishnan
MSMatthew P. Sharron
Matthew P. Sharron
JBJennifer Dien Bard
Jennifer Dien Bard